Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 7,902 | 77,971 | 2,716 | 2,474 | 3,294 |
| Cost of Goods | 1,269 | 819 | 905 | 205 | 230 |
| Gross Profit | 6,633 | 77,152 | 1,811 | 2,269 | 3,064 |
| Operating Expenses | 124,577 | 120,044 | 214,565 | 172,931 | 158,764 |
| Operating Income | -117,675 | -42,073 | -211,849 | -170,457 | -155,470 |
| Other Income | 9,192 | 9,367 | 10,219 | 10,132 | 8,642 |
| Pre-tax Income | -108,483 | -32,706 | -201,630 | -160,325 | -146,828 |
| Net Income Continuous | -108,483 | -32,706 | -201,630 | -160,325 | -146,828 |
| Net Income | $-108,483 | $-32,706 | $-201,630 | $-160,325 | $-146,828 |
| EPS Basic Total Ops | -1.80 | -0.54 | -3.37 | -2.68 | -2.46 |
| EPS Basic Continuous Ops | -1.80 | -0.54 | -3.37 | -2.68 | -2.46 |
| EPS Diluted Total Ops | -1.80 | -0.54 | -3.37 | -2.68 | -2.46 |
| EPS Diluted Continuous Ops | -1.80 | -0.54 | -3.37 | -2.68 | -2.46 |
| EPS Diluted Before Non-Recurring Items | -1.80 | -0.55 | -2.81 | -2.68 | N/A |
| EBITDA(a) | $-118,893 | $-35,483 | $-216,470 | $-174,517 | $-158,326 |